Emulate Competitors, Revenue, Alternatives and Pricing

Claim your profile


Boston, MA USA
Total Funding:$142.3M
Lead Investor(s):Founders Fund

Estimated Revenue & Financials

  • Emulate's estimated annual revenue is currently $15.3M per year.(?)
  • Emulate received $36.0M in venture funding in June 2018.
  • Emulate's estimated revenue per employee is $155,000
  • Emulate's total funding is $142.3M.

Employee Data

  • Emulate has 99 Employees.(?)
  • Emulate grew their employee count by -17% last year.
  • Emulate currently has 12 job openings.

We work at the intersection of biology, engineering, and design, developing technologies that emulate human biology. Our products are enabling a new era of precision medicine and the development of applications for personalized health. Our Human Emulation System, which uses Organs-on-Chips technology, is being used by industry, government, and academia to understand how different diseases, medicines, chemicals and foods affect human health. The system offers researchers a new standard for predicting human response - with greater precision and control than today's cell culture or animal-based experimental methods. We are also leading a bold, new precision medicine initiative with our clinical partners. Named "Patient-on-a-Chip," the program is developing personalized chips with patients' own cells. This initiative will help transform the way each of us understands our own bodies and manages our own health. Research conducted using our Organ-Chips has been published in high-impact scientific journals, including Science. In addition, Organ-Chips have been acquired by the Museum of Modern Art (MoMA) in New York for their permanent collection, and have also been awarded Product Design of the Year 2015 by London's Design Museum. Our founding team pioneered the original Organs-on-Chips technology during their residency within the Wyss Institute for Biologically Inspired Engineering at Harvard University.